Press release
Global Neurodegenerative Disease Market Assessment top key Players like Novartis, Pfizer, Merck Serono, Biogen Idec, TEVA, UCB, Boehringer Ingelheim, Sanofi, GlaxoSmithKline and many more.
InsightAce Analytic Pvt. Ltd. announces the release of market assessment report on ' Global Neurodegenerative Disease Market Assessment – Revenue Forecast, Clinical Trial/Pipeline Analysis, Historic Revenue and Forecast Till 2027 ’Request for ToC/Proposal: https://bit.ly/2k1hkZG
Neurodegenerative diseases are incurable and debilitating conditions that result in progressive degeneration and / or death of nerve cells. Degenerative nerve diseases include alzheimer's disease, amyotrophic lateral sclerosis, friedreich's ataxia, huntington's disease, lewy body disease, parkinson's disease, spinal muscular atrophy.
The market of neurodegenerative disease is boosted by the raising awareness among people and the research and developmental activities undertaken by various research institutions and companies to develop effective therapies to treat them. However, the complex nature of the diseases and the lack of knowledge about their causative factors in most cases hamper the advancement of research and development into effective treatment methods. Current the therapies only help alleviating symptoms rather than curing. Due to rapid increasing prevalence, alzheimer's disease and parkinson's disease pose to be the most challenging diseases. Entry of generics to the already existing products can be a challenge to the market. Reformulating marketed drugs shall provide great opportunities to the neurodegenerative disease market.
Some of the molecules under development include VY AADC is gene therapy from Voyager Therapeutics which is in phase 2 stage of development for the treatment of parkinson’s disease, Crenezumab of Roche is in Phase 3 for Alzheimer’s disease, Gocovri, Ingrezza , Radicava are some of the products approved in 2017 for neurodegenerative diseases.
Some of the key players include Novartis,Pfizer ,Merck Serono ,Biogen Idec , TEVA ,UCB , Boehringer Ingelheim, Sanofi, GlaxoSmithKline
Curious about this latest version of report?
Obtain Report Details @ https://bit.ly/2k1hkZG
Market Segments
Global Neurodegenerative Medicine Market by Drug Class
o NMDA
o Dopamine Inhibitors
o SSRIs
Global Neurodegenerative Medicine Market by Application
o Parkinson’s Disease
o Huntingtion Disease
o Alzheimer’s Disease
o Amyotrophic lateral Sclerosis
Global Neurodegenerative Medicine Market by Region
• Europe
o U.K.
o Germany
o France
o Italy
o Spain
o Russia
o Rest of Europe
• North America
o U.S.
o Canada
• Asia Pacific
o India
o China
o Japan
o South Korea
o Australia & New Zealand
o Latin America
o Brazil
o Mexico
o Rest of Latin America
• Middle East & Africa
o GCC Countries
o South Africa
o Rest of Middle East & Africa
• Major Qualitative Insights
o Industry Overview
o Key Market Trends
o Market Drivers and Challenges
o Market Size and Forecast
o Key News/Industry Activities
o Major Mergers & Acquisition
o Competitive Landscape
• Company Overview
o Financial Performance
o Key Development
o Latest Strategic Developments
Why should buy this report:
• To receive a comprehensive analysis of the prospects for Global Neurodegenerative Disease Market
• To receive historic and forecast data of Global Neurodegenerative Disease Market
• Sales in leading country from 2013-2025, including leading countries from developed and developing regions
• To discover the views of industry experts in the Global Neurodegenerative Disease Market
• To determine the forces and factor that influences the market for Global Neurodegenerative Disease Market : drivers, challenges, and opportunities
• To find out where the Global Neurodegenerative Disease Market is heading – both technologically and commercially from 2013-2025
• Report Include tables of content and its value and description by region and Country
For More Information @ https://bit.ly/2k1hkZG
Neha Joshi,
InsightAce Analytic
Deccan, FC Road, Pune -411004
Email us: info@insightaceanalytic.com
Call: +1 718 593 4405
Website: www.insightaceanalytic.com
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Neurodegenerative Disease Market Assessment top key Players like Novartis, Pfizer, Merck Serono, Biogen Idec, TEVA, UCB, Boehringer Ingelheim, Sanofi, GlaxoSmithKline and many more. here
News-ID: 1829198 • Views: …
More Releases from InsightAce Analytic Pvt. Ltd.

Organic Feminine Care Market to Benefit from Increasing Government Initiatives a …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Organic Feminine Care Market Size, Share & Trends Analysis Report By Product Type (Sanitary Pads, Tampons, Menstrual Cups, Liners and Shields, Others), by Nature (Disposable, Reusable), by Age Group (Upto 18 Years, 19-30 Years, 31-40 Years, 41 Years and Above), by Distribution Channel (Supermarkets and hypermarkets, Pharmacy, Online Stores, Others)- Market Outlook And Industry Analysis…

Intravenous Immunoglobulin Market Key Players Analysis - Biotest AG, Octapharma …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Intravenous Immunoglobulin Market Size, Share & Trends Analysis Report By Application (Hypogammaglobulinemia, CIDP, Congenital AIDS), By Distribution Channel (hospital pharmacies, speciality pharmacies), Region, Market Outlook And Industry Analysis 2031"
The global Intravenous Immunoglobulin market is estimated to reach over USD 21.22 billion by 2031, exhibiting a CAGR of 6.60% during the forecast period.
Get Free Access…

Exascale Computing Market Key Players Analysis- Hewlett Packard Enterprise Compa …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Exascale Computing Market - (By Component (Hardware, Software, Services), By Deployment (On-premises, Cloud-based), By Customer Type (Government & Defense, Healthcare & Biosciences, Financial Services, Research & Academia, Manufacturing & Energy, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the latest research by InsightAce Analytic, the Global Exascale Computing Market is valued at…

Plasma Fractionation Market Robust Expansion is expected to 2031
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Plasma Fractionation Market- (By Product (Immune-Globulins(Intravenous Immune-Globulins, Subcutaneous Immune-Globulins, Other Immune-Globulins), Coagulation Factor Concentrates (Factor VIII, Factor IX, Von Willebrand Factor, Prothrombin Complex Concentrate, Fibrinogen Concentrates, Factor XIII, Others), Albumin, Protease Inhibitors, Other Plasma Products), By Application (Neurology, Immunology, Hematology, Critical Care, Pulmonology, Hemato-Oncology, Rheumatology, Others), By End-User (Hospitals & Clinics, Clinical Research Laboratories, Academic Institutes)),…
More Releases for Neurodegenerative
Growing Prevalence Of Neurodegenerative Disorders Fuels Neurodegenerative Disord …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Neurodegenerative Disorder Therapeutics Market Size Growth Forecast: What to Expect by 2025?
In recent times, the market size for therapeutics for neurodegenerative disorders has seen robust growth. The growth is expected to rise from $18.53 billion in 2024 to $20.04 billion in 2025, maintaining a compound annual growth rate…
Growing Prevalence Of Neurodegenerative Disorders Fuels Neurodegenerative Disord …
"The Neurodegenerative Disorder Therapeutics Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Current Neurodegenerative Disorder Therapeutics Market Size and Its Estimated Growth Rate?
The neurodegenerative disorder therapeutics market has shown strong growth, expected to increase from $18.53 billion in 2024 to $20.04 billion…
Growing Prevalence Of Neurodegenerative Disorders Fuels Neurodegenerative Disord …
How Is the Neurodegenerative Disorder Therapeutics Market Projected to Grow, and What Is Its Market Size?
Seen significant expansion in recent years, the market size for neurodegenerative disorder therapeutics is predicted to climb from $18.53 billion in 2024 to $20.04 billion in 2025, maintaining a compound annual growth rate (CAGR) of 8.1%. The prior growth phase can be credited to factors such as an aging society, an upsurge in neurodegenerative disorder…
Growing Prevalence Of Neurodegenerative Disorders Fuels Neurodegenerative Disord …
How Is the Neurodegenerative Disorder Therapeutics Market Projected to Grow, and What Is Its Market Size?
Seen significant expansion in recent years, the market size for neurodegenerative disorder therapeutics is predicted to climb from $18.53 billion in 2024 to $20.04 billion in 2025, maintaining a compound annual growth rate (CAGR) of 8.1%. The prior growth phase can be credited to factors such as an aging society, an upsurge in neurodegenerative disorder…
Growing Prevalence Of Neurodegenerative Disorders Fuels Neurodegenerative Disord …
How Is the Neurodegenerative Disorder Therapeutics Market Projected to Grow, and What Is Its Market Size?
Seen significant expansion in recent years, the market size for neurodegenerative disorder therapeutics is predicted to climb from $18.53 billion in 2024 to $20.04 billion in 2025, maintaining a compound annual growth rate (CAGR) of 8.1%. The prior growth phase can be credited to factors such as an aging society, an upsurge in neurodegenerative disorder…
Novel Antibodies in Neurodegenerative Disease Treatment
Neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease, represent some of the most challenging medical conditions due to their progressive nature and lack of effective treatments. Novel antibodies are emerging as promising therapeutic agents, offering targeted and innovative approaches to slow disease progression and improve patient outcomes. This article explores the role of novel antibodies in the treatment of neurodegenerative diseases, highlighting their mechanisms of action and therapeutic potential.
Download…